Regression of coronary atherosclerosis: is it possible?

This publication has 12 references indexed in Scilit:

• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN
  The Lancet, 1986
• Diet, Lipoproteins, and the Progression of Coronary Atherosclerosis
  New England Journal of Medicine, 1985
• The Relation of Risk Factors to the Development of Atherosclerosis in Saphenous-Vein Bypass Grafts and the Progression of Disease in the Native Circulation
  New England Journal of Medicine, 1984
• Mevinolin Plus Colestipol in Therapy for Severe Heterozygous Familial Hypercholesterolemia
  Annals of Internal Medicine, 1984
• A study of atherosclerosis regression in Macaca mulatta
  Experimental and Molecular Pathology, 1984
• The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
  Proceedings of the National Academy of Sciences, 1980